Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
It is time to move forward with Waldenström!
[waldenström macroglobulinemia]
In
this
issue
of
Blood
,
Roccaro
et
al
demonstrate
high
expression
of
C-X-C
chemokine
receptor
type
4
(
CXCR
4
)
mutation
in
Waldenström
macroglobulinemia
(
WM
)
,
a
marker
of
tumor
aggression
and
drug
resistance
.
In
vivo
analysis
with
an
anti-
CXCR
4
antibody
reversed
this
aggression
,
setting
the
stage
for
prospective
studies
in
this
forgotten
disease
.